phase 1
ii 1
multicenter 1
trial 1
hypercvad 1
mtxarac 1
rituximab 1
patients 2
previously 1
untreated 1
mantle 1
cell 1
lymphoma 2
swog 2
natural 1
history 1
cns 1
relapse 1
aggressive 1
nonhodgkins 1
followup 1
analysis 1
southwest 1
oncology 1
group 1
